Novartis has announced a massive investment in manufacturing and R&D facilities in the US, including seven new facilities, in ...

The top-line results of the APOLLOE4 trial showed that valitramiprosate (ALZ-801) was unable to slow down cognitive decline ...

For Reuters Pharma Europe 2025, pharmaphorum is providing coverage courtesy NAVLIN Daily, a pricing and market access ...

Top NHS doctor, CEO out. Across the pond, NHS England is also seeing big changes with Sir Stephen Powis announcing his plans ...

The oral drug – Johnson & Johnson's Balversa (erdafitinib) – will become an option for adults with metastatic or unresectable ...

AKT inhibitor Truqap (capivasertib) has been cleared by NICE for use in combination with standard therapy fulvestrant for ...

Robert F Kennedy Jr's controversial views on vaccines were on display this week during an interview with CBS News in which he ...

Since 1938, animal testing has been required by the FDA before any new drug can proceed through clinical trials and receive ...

Following the success of the Boston and European editions, the ESG in Life Sciences Summit West is bringing together senior ...

Incyte's infringement lawsuit is claiming that Sun Pharma's drug infringes a US patent (No. 9,662,335) it holds on the use of ...

A notice posted by the NIH in February said the agency would slash its funding of indirect costs borne by research teams at ...